LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 60 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | -20.0% | 29,636 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -50.0% | 29,636 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -70.6% | 29,636 | 0.0% | 0.00% | – |
| Q4 2021 | $68,000 | -49.6% | 29,636 | 0.0% | 0.00% | – |
| Q3 2021 | $135,000 | +3.1% | 29,636 | 0.0% | 0.00% | – |
| Q2 2021 | $131,000 | -89.8% | 29,636 | -83.3% | 0.00% | – |
| Q1 2021 | $1,289,000 | -7.3% | 177,029 | -2.8% | 0.00% | – |
| Q4 2020 | $1,390,000 | +13.3% | 182,136 | +34.8% | 0.00% | – |
| Q3 2020 | $1,227,000 | +2.9% | 135,078 | -4.1% | 0.00% | – |
| Q2 2020 | $1,192,000 | +138.9% | 140,847 | +39.5% | 0.00% | – |
| Q1 2020 | $499,000 | -19.0% | 100,977 | +18.0% | 0.00% | – |
| Q4 2019 | $616,000 | -33.7% | 85,602 | -0.4% | 0.00% | – |
| Q3 2019 | $929,000 | -19.6% | 85,925 | -3.3% | 0.00% | – |
| Q2 2019 | $1,156,000 | +33.0% | 88,889 | +1.1% | 0.00% | – |
| Q1 2019 | $869,000 | -0.5% | 87,951 | +4.7% | 0.00% | – |
| Q4 2018 | $873,000 | – | 83,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,466,783 | $5,758,000 | 0.09% |
| HARBOR CAPITAL ADVISORS, INC. | 226,731 | $154,000 | 0.07% |
| Sio Capital Management, LLC | 182,630 | $124,000 | 0.04% |
| Virtu Financial LLC | 71,475 | $49,000 | 0.00% |
| Independence Bank of Kentucky | 10,200 | $7,000 | 0.00% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $10,000 | 0.00% |
| Endurance Wealth Management, Inc. | 1,500 | $12,000 | 0.00% |
| Baker Brothers Advisors | 451,478 | $307,000 | 0.00% |
| Texas Yale Capital Corp. | 20,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,900 | $54,000 | 0.00% |